• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Events
  • Education
  • Podcast
  • Business Directory
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
  • Patient perspective

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

New data shows Covid-19 vaccines meet strict regulatory safety standards

5th February 2021 by PIP editor Leave a Comment

 

Data published from UK’s independent medicines regulator confirms approved vaccines meet strict regulatory standards for safety.

 

Routine safety monitoring and analysis of the approved COVID-19 vaccines by the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), shows that the safety of these vaccines remains as high as expected from the clinical trial data that supported the approvals. The safety profile of the vaccines remains positive and the benefits continue to far outweigh any known side-effects.

 

Over 10 million doses of the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines have been given across the UK and the MHRA has gathered a large amount of safety data. Data published today shows 22,820 reports of suspected side effects or an overall reporting rate of 3 in 1,000 doses of vaccine administered from 9 December 2020 to 24 January 2021. This reassuring data has shown that the vast majority of reported side effects are mild and all are in line with most types of vaccine, including the seasonal flu vaccine. These include sore arms and mild ‘flu-like’ symptoms, which reflect normal immune response to vaccines and are short-lasting.

 

The MHRA has today published its safety surveillance strategy for monitoring the safety of all UK-approved COVID-19 vaccines. This has been informed by the Government’s independent advisory body, the Commission on Human Medicines, and expertise across the UK public health sector.

 

The MHRA has also published today the first of what will be regular COVID-19 vaccine safety reports. These provide details on the suspected side-effects to the vaccines reported through its safety monitoring system, the Yellow Card scheme. This data has been thoroughly analysed by the MHRA’s scientists and safety experts together with all other sources of evidence.

 

The MHRA is working to actively promote reporting on COVID-19 vaccines from patients and healthcare professionals to the Coronavirus Yellow Card scheme. Anyone who has received the vaccine and thinks they may have suffered a side-effect, even suspected, is encouraged to report it to the MHRA here.

 

Safety monitoring of all medicines and vaccines used by the wider UK population is a key role of the MHRA. The safety of COVID-19 vaccines is continually monitored throughout their use in healthcare practice to ensure they remain safe and effective. The regulator does this by identifying and comparing new and emerging data from multiple sources with what it already knows from large-scale clinical trials.

Dr June Raine, MHRA Chief Executive, said:

 

“Vaccines are the most effective way to protect against COVID-19 and save lives and prevent serious complications from this terrible virus. The data we have collected provides further reassurance that the COVID-19 vaccines are safe and continue to meet the rigorous regulatory standards required for all vaccines. We remain confident that the benefits of these vaccines outweigh any risks.

 

“Our priority is to ensure the public has safe and effective vaccines and we will continue to analyse, monitor and review all the safety data for these vaccines. I’d like to thank everyone who has reported a potential side effect on us – every report matters.”

Next article  Scottish CMO classifies COVID-19 as a notifiable disease

 

This article is being shared under the Open Government Copyright licence.

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Filed Under: News Tagged With: Covid 19, vaccination

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Stay connected with us

  • E-mail
  • Facebook
  • Instagram
  • LinkedIn
  • Phone
  • Twitter

Your Pharmacy in Practice Prescription

Categories

Pharmacy in Practice member login

 
 
Forgot Password

Register for our upcoming live Q&A

https://www.youtube.com/watch?v=vVNhKJWCGFA

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.